Lorazepam Merck

Lorazepam Merck may be available in the countries listed below.

Ingredient matches for Lorazepam Merck

Lorazepam

Lorazepam is reported as an ingredient of Lorazepam Merck in the following countries:

• Netherlands

International Drug Name Search

Leviben

Leviben may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Leviben

Albendazole

Albendazole is reported as an ingredient of Leviben in the following countries:

• New Zealand

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Leviben in the following countries:

• New Zealand

International Drug Name Search

Fibral

Fibral may be available in the countries listed below.

Ingredient matches for Fibral

Fenofibrate

Fenofibrate is reported as an ingredient of Fibral in the following countries:

• Myanmar

International Drug Name Search

diflorasone topical

Generic Name: diflorasone topical (dye FLOR a sone)

Brand names: ApexiCon, ApexiCon E, Maxiflor, Psorcon E, Florone, Psorcon, Florone E

What is diflorasone topical?

Diflorasone is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.

Diflorasone topical is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

Diflorasone topical may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about diflorasone topical?

Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.

Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. Plastic film covering (such as plastic wrap) is sometimes used when treating psoriasis. Follow your doctor's instructions.

If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with diflorasone topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects.

Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period. Contact your doctor if your condition does not improve, or if you develop signs of a bacterial, fungal, or viral skin infection.

What should I discuss with my healthcare provider before using diflorasone topical?

Do not use this medication if you are allergic to diflorasone.

Before using diflorasone topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.

Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether diflorasone topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period.

How should I use diflorasone topical?

Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.

Wash your hands before and after using diflorasone topical, unless you are using the medication to treat the skin on your hands.

Apply a small amount to the affected area and rub it gently into the skin. Do not use this medication over a large area of skin.

Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. Plastic film covering (such as plastic wrap, plastic gloves, or a shower cap) is sometimes used to cover areas of psoriasis that are treated with diflorasone topical. Follow your doctor's instructions.

Avoid plastic covering over skin lesions that are oozing or draining pus or any type of fluid.

If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with diflorasone topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects.

Contact your doctor if your condition does not improve, or if you develop signs of a bacterial, fungal, or viral skin infection. It is important to use diflorasone topical regularly to get the most benefit.

If you are treating psoriasis, use the medication for at least a few days after the skin clears. Stopping too soon could cause a relapse.

To be sure this medication is not causing harmful effects with long-term use, you may need blood tests. Do not miss any scheduled appointments.

Store diflorasone topical at room temperature away from moisture and heat. Keep from freezing.

What happens if I miss a dose?

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of diflorasone is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.

What should I avoid while using diflorasone topical?

Diflorasone topical should not be used to treat any skin condition your doctor has not prescribed it for.

Avoid getting this medication in your eyes. If contact does occur, rinse with water. Do not use diflorasone topical on broken or infected skin. Also avoid using this medication in open wounds.

Diflorasone topical side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing diflorasone topical through your skin, such as:

• 
  

  blurred vision, or seeing halos around lights;

  
  


• 
  

  mood changes;

  
  


• 
  

  sleep problems (insomnia);

  
  


• 
  

  weight gain, puffiness in your face; or

  
  


• 
  

  muscle weakness, feeling tired.

  
  

Less serious side effects may include:

• 
  

  mild skin itching, burning, or dryness;

  
  


• 
  

  thinning or softening of your skin;

  
  


• 
  

  skin rash or irritation around your mouth;

  
  


• 
  

  swollen hair follicles;

  
  


• 
  

  changes in color of treated skin;

  
  


• 
  

  blisters, pimples, or crusting of treated skin; or

  
  


• 
  

  stretch marks.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect diflorasone topical?

It is not likely that other drugs you take orally or inject will have an effect on topically applied diflorasone topical. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More diflorasone topical resources

• Diflorasone topical Side Effects (in more detail)
• Diflorasone topical Use in Pregnancy & Breastfeeding
• Diflorasone topical Drug Interactions
• Diflorasone topical Support Group
• 0 Reviews for Diflorasone - Add your own review/rating

• Apexicon Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• Apexicon Prescribing Information (FDA)


• Apexicon Advanced Consumer (Micromedex) - Includes Dosage Information


• Apexicon E Prescribing Information (FDA)


• Florone Prescribing Information (FDA)


• Psorcon Monograph (AHFS DI)


• psorcon Prescribing Information (FDA)

Compare diflorasone topical with other medications

• Atopic Dermatitis
• Eczema
• Psoriasis
• Skin Rash
• Urticaria

Where can I get more information?

• Your pharmacist can provide more information about diflorasone topical.

See also: diflorasone side effects (in more detail)

Vitamin C-mp

Vitamin C-mp may be available in the countries listed below.

Ingredient matches for Vitamin C-mp

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamin C-mp in the following countries:

• Germany

International Drug Name Search

Somatuline PR

Somatuline PR may be available in the countries listed below.

Ingredient matches for Somatuline PR

Lanreotide

Lanreotide is reported as an ingredient of Somatuline PR in the following countries:

• Taiwan

Lanreotide acetate (a derivative of Lanreotide) is reported as an ingredient of Somatuline PR in the following countries:

• Czech Republic


• Finland


• Hong Kong


• Lithuania


• Luxembourg


• Netherlands


• Poland


• Slovenia

International Drug Name Search

Ramipril / Hydrochlorthiazid Actavis

Ramipril/Hydrochlorthiazid Actavis may be available in the countries listed below.

Ingredient matches for Ramipril/Hydrochlorthiazid Actavis

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramipril/Hydrochlorthiazid Actavis in the following countries:

• Denmark

Ramipril

Ramipril is reported as an ingredient of Ramipril/Hydrochlorthiazid Actavis in the following countries:

• Denmark

International Drug Name Search

Tretochinolo

Tretochinolo may be available in the countries listed below.

Ingredient matches for Tretochinolo

Tretoquinol

Tretochinolo (DCIT) is also known as Tretoquinol (Prop.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Lucentis

In the US, Lucentis (ranibizumab ophthalmic) is a member of the drug class anti-angiogenic ophthalmic agents and is used to treat Diabetic Retinopathy, Macular Degeneration and Macular Edema.

US matches:

• Lucentis


• Lucentis ophthalmic

UK matches:

• Lucentis 10 mg/ml solution for injection
• Lucentis 10 mg/ml solution for injection (SPC)

Ingredient matches for Lucentis

Ranibizumab

Ranibizumab is reported as an ingredient of Lucentis in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Croatia (Hrvatska)


• Denmark


• France


• Germany


• Greece


• Hungary


• Indonesia


• Ireland


• Italy


• Netherlands


• New Zealand


• Norway


• Peru


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Rispimed

Rispimed may be available in the countries listed below.

Ingredient matches for Rispimed

Risperidone

Risperidone is reported as an ingredient of Rispimed in the following countries:

• Poland

International Drug Name Search

Loratadine Teva

Loratadine Teva may be available in the countries listed below.

Ingredient matches for Loratadine Teva

Loratadine

Loratadine is reported as an ingredient of Loratadine Teva in the following countries:

• Belgium


• France


• Israel


• Slovakia

International Drug Name Search

Bactroban Nasal

Generic Name: mupirocin (Nasal route)

mue-PIR-oh-sin

Commonly used brand name(s)

In the U.S.

• Bactroban

Available Dosage Forms:

• Ointment

Therapeutic Class: Antibiotic

Uses For Bactroban

Mupirocin is used inside the nose to kill a certain bacteria, known as Staphylococcus aureus (also known as “staph”), that has become resistant to the antibiotic methicillin.

This medicine is available only with your doctor's prescription.

Before Using Bactroban

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on this medicine have been done only in adult patients and there is no specific information comparing use of nasal mupirocin in children with use in other age groups. However, a study in newborns and infants found that significant amounts of nasal mupirocin were absorbed into the body.

Geriatric

No information is available comparing use of nasal mupirocin in the elderly with use in other adults. However, it has not been reported to cause different side effects or other problems in older people than it does in younger adults.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper Use of Bactroban

To use the nasal ointment

• First, wash your hands.


• Apply approximately 1/2 of the ointment from the single-use tube directly from the tube into one nostril. Then apply the remainder of the ointment directly into the other nostril.


• Close your nostrils by pressing the sides of the nose together and then releasing them. Do this over and over again for approximately one minute. You may also press the sides of the nose together and gently massage the nose. These methods will help spread the medicine throughout the inside of the nostrils.


• Discard the tube after using. The tube only has enough medicine for one dose in each nostril.


• Be careful not to touch your eyes.


• Immediately after using the nose ointment, wash your hands to remove any medicine that may be on them.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For nasal dosage form (nasal ointment):
  
  • To kill Staphylococcus aureus (“staph”) bacteria in the nose:
    
    • Adults and children 12 years of age and older—Approximately 1/2 of the ointment from a single-use tube squeezed into each nostril two times a day (morning and evening) for five days.
    
    
    • Children less than 12 years of age—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Bactroban

Keep this medicine away from your eyes. If this medicine gets in the eyes, it may cause severe burning and tearing that may last days or weeks. If this occurs, contact your doctor.

Do not use any other medicine in your nose without first checking with your doctor.

If severe nasal irritation occurs, discontinue use of this medicine and contact your doctor.

Bactroban Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

Less common

• Chest congestion


• cough

Rare

• Ear pain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Headache

Less common

• Burning or stinging in the nose


• change in taste


• itching


• sore throat


• stuffy or runny nose

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bactroban Nasal side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Bactroban Nasal resources

• Bactroban Nasal Side Effects (in more detail)
• Bactroban Nasal Use in Pregnancy & Breastfeeding
• Bactroban Nasal Support Group
• 11 Reviews for Bactroban Nasal - Add your own review/rating

Compare Bactroban Nasal with other medications

• Nasal Carriage of Staphylococcus aureus
• Skin and Structure Infection

Pektrol

Pektrol may be available in the countries listed below.

Ingredient matches for Pektrol

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Pektrol in the following countries:

• Russian Federation

International Drug Name Search

Lafigesic

Lafigesic may be available in the countries listed below.

Ingredient matches for Lafigesic

Clonixin

Clonixin lysine salt (a derivative of Clonixin) is reported as an ingredient of Lafigesic in the following countries:

• Chile

International Drug Name Search

Lactulose Biogaran

Lactulose Biogaran may be available in the countries listed below.

Ingredient matches for Lactulose Biogaran

Lactulose

Lactulose is reported as an ingredient of Lactulose Biogaran in the following countries:

• France

International Drug Name Search

Flumazénil Dakota Pharm

Flumazénil Dakota Pharm may be available in the countries listed below.

Ingredient matches for Flumazénil Dakota Pharm

Flumazenil

Flumazenil is reported as an ingredient of Flumazénil Dakota Pharm in the following countries:

• France

International Drug Name Search

Droxidopa

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0023651-95-8

Chemical Formula

C9-H11-N-O5

Molecular Weight

213

Therapeutic Category

Treatment of Parkinson's disease

Chemical Name

(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine

Foreign Names

• Droxidopa (Latin)
• Droxidopa (German)
• Droxidopa (French)
• Droxidopa (Spanish)

Generic Name

• Droxidopa (OS: JAN, USAN)

Brand Name

• Dops
  Dainippon Sumitomo, Japan

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Solu-Dacortina

Solu-Dacortina may be available in the countries listed below.

Ingredient matches for Solu-Dacortina

Prednisolone

Prednisolone 21-(sodium succinate) (a derivative of Prednisolone) is reported as an ingredient of Solu-Dacortina in the following countries:

• Portugal

International Drug Name Search

Ox-Pam

Ox-Pam may be available in the countries listed below.

Ingredient matches for Ox-Pam

Oxazepam

Oxazepam is reported as an ingredient of Ox-Pam in the following countries:

• New Zealand

International Drug Name Search

Lignocaina

Lignocaina may be available in the countries listed below.

Ingredient matches for Lignocaina

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lignocaina in the following countries:

• Argentina

International Drug Name Search

Lozam

Lozam may be available in the countries listed below.

Ingredient matches for Lozam

Clobazam

Clobazam is reported as an ingredient of Lozam in the following countries:

• Bangladesh

International Drug Name Search

Bacterfin

Bacterfin may be available in the countries listed below.

Ingredient matches for Bacterfin

Clarithromycin

Clarithromycin is reported as an ingredient of Bacterfin in the following countries:

• Ecuador

International Drug Name Search

Vector

Vector may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vector

Cypermethrin

Cypermethrin is reported as an ingredient of Vector in the following countries:

• Ireland


• United Kingdom

International Drug Name Search

Leodrin

Leodrin may be available in the countries listed below.

Ingredient matches for Leodrin

Alendronic Acid

Alendronic Acid is reported as an ingredient of Leodrin in the following countries:

• Chile


• Peru

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Leodrin in the following countries:

• Chile


• Ecuador

International Drug Name Search

Oropram

Oropram may be available in the countries listed below.

Ingredient matches for Oropram

Citalopram

Citalopram is reported as an ingredient of Oropram in the following countries:

• Georgia


• Malta

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Oropram in the following countries:

• Hungary

International Drug Name Search

Ledolper

Ledolper may be available in the countries listed below.

Ingredient matches for Ledolper

Brotizolam

Brotizolam is reported as an ingredient of Ledolper in the following countries:

• Japan

International Drug Name Search

Meloxicam Alpharma

Meloxicam Alpharma may be available in the countries listed below.

Ingredient matches for Meloxicam Alpharma

Meloxicam

Meloxicam is reported as an ingredient of Meloxicam Alpharma in the following countries:

• Finland


• Portugal

International Drug Name Search

Locoid Lipid

Locoid Lipid may be available in the countries listed below.

Ingredient matches for Locoid Lipid

Hydrocortisone

Hydrocortisone 17α-butyrate (a derivative of Hydrocortisone) is reported as an ingredient of Locoid Lipid in the following countries:

• Norway


• Sweden

International Drug Name Search

Mecamylamine Hydrochloride

Mecamylamine Hydrochloride may be available in the countries listed below.

Ingredient matches for Mecamylamine Hydrochloride

Mecamylamine

Mecamylamine Hydrochloride (BANM) is known as Mecamylamine in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ezith

Ezith may be available in the countries listed below.

Ingredient matches for Ezith

Azithromycin

Azithromycin is reported as an ingredient of Ezith in the following countries:

• Bangladesh

International Drug Name Search

Doxorubicin

Pronunciation: dox-oh-ROO-bi-sin
Generic Name: Doxorubicin
Brand Name: Adriamycin

Doxorubicin is for intravenous (IV) use only and should only be given under the supervision of a doctor experienced in the use of cancer chemotherapy agents. If Doxorubicin accidentally leaks into surrounding tissue, the skin and/or muscle may be severely damaged. Notify your doctor immediately if redness, pain, or swelling at or around the injection site occur.

Doxorubicin may cause severe and possibly life-threatening heart problems (eg, heart failure). These problems may occur during therapy or sometimes months to years after receiving Doxorubicin. In some cases, heart problems are irreversible. The risk may be increased if you are using certain medicines that may affect heart function (eg, trastuzumab), or have a history of heart problems, radiation treatment to the chest area, or previous therapy with other anthracyclines (eg, epirubicin). The risk of developing heart problems varies depending on your dose and condition, although it can occur at any dose whether or not you are at risk. Notify your doctor immediately if you develop cough; fast, slow, or irregular heartbeat; shortness of breath; sudden, unexplained weight gain; or swelling of the hands, ankles, or feet.

Another type of cancer (acute myelogenous leukemia [AML]) and a certain blood problem (myelodysplastic syndrome [MDS]) have been reported in patients treated with anthracyclines, including Doxorubicin. The risk varies depending on your dose and other medicines and/or radiation therapy. Discuss any questions or concerns with your doctor.

Doxorubicin may cause bone marrow suppression. Notify your doctor immediately if you develop easy bruising or bleeding, unusual tiredness or weakness, or signs of an infection (eg, fever, chills, persistent sore throat).

Tell your doctor if you have liver problems because your dose will have to be decreased. Your doctor will closely monitor you while you are using Doxorubicin.

Doxorubicin is used for:

Treating various types of cancer.

Doxorubicin is an antineoplastic antibiotic. It works by killing cancer cells.

Do NOT use Doxorubicin if:

• you are allergic to any ingredient in Doxorubicin or to similar medicines (eg, epirubicin)


• you have certain bone marrow problems (eg, low blood platelet levels, low red blood cell levels, low white blood cell levels)


• you have severe liver problems


• you have severe heart problems, severe irregular heartbeat, or recently had a heart attack


• you have taken or will be taking palifermin within 24 hours before or after using Doxorubicin

Contact your doctor or health care provider right away if any of these apply to you.

Before using Doxorubicin:

Some medical conditions may interact with Doxorubicin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are able to become pregnant


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have swelling or soreness of the mouth or tongue, blood vessel disease, an infection, or liver problems


• if you plan to receive any vaccines


• if you are older than 50 years old


• if you have a history of heart problems or radiation treatment (or are currently receiving radiation treatment), or if you have previously received Doxorubicin or similar medicines (eg, epirubicin, daunorubicin)


• if you are taking medicines that may affect heart function (eg, calcium channel blockers, trastuzumab). Ask your doctor if you are unsure if any of your medicines may affect heart function

Some MEDICINES MAY INTERACT with Doxorubicin. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Calcium channel blockers (eg, diltiazem, verapamil), cyclophosphamide, or trastuzumab because the risk of heart problems (eg, heart failure) may be increased


• Cyclosporine, cytarabine, paclitaxel, progesterone, or streptozocin because it may increase the risk of Doxorubicin's side effects


• Phenobarbital because it may decrease Doxorubicin's effectiveness


• Anticoagulants (eg, warfarin) because the risk of their side effects may be increased


• Palifermin because if mouth or tongue sores develop, they may be more severe or last longer


• Hydantoins (eg, phenytoin) because their effectiveness may be decreased by Doxorubicin


• Medicines that may harm the liver (eg, acetaminophen, methotrexate, ketoconazole, isoniazid, certain medicines for HIV infection) because the risk of Doxorubicin's side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver

This may not be a complete list of all interactions that may occur. Ask your health care provider if Doxorubicin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Doxorubicin:

Use Doxorubicin as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Doxorubicin is usually administered as an injection at your doctor's office, hospital, or clinic. Ask your doctor any questions that you may have about Doxorubicin.


• If Doxorubicin contains particles or is discolored, or if the vial is cracked or damaged in any way, do not use it.


• Drinking extra fluids while you are using Doxorubicin is recommended. Check with your doctor for instructions.


• Your doctor may prescribe another medicine to lessen nausea and vomiting that can occur when using Doxorubicin. Discuss any questions with your doctor.


• If Doxorubicin accidentally spills on your skin, wash it off immediately with soap and water.


• Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor or pharmacist to explain local regulations for proper disposal.


• If you miss a dose of Doxorubicin, contact your doctor immediately.

Ask your health care provider any questions you may have about how to use Doxorubicin.

Important safety information:

• Doxorubicin may reduce the number of clot-forming cells (platelets) in your blood. To prevent bleeding, avoid situations in which bruising or injury may occur. Report any unusual bleeding, bruising, blood in stools, or dark, tarry stools to your doctor.


• Doxorubicin may lower your body's ability to fight infection. Prevent infection by avoiding contact with people with colds or other infections. Notify your doctor of any signs of infection, including fever, sore throat, rash, or chills.


• Caregivers of children should take precautions (eg, wear latex gloves) to prevent contact with the patient's urine and other body fluids for at least 5 days after treatment.


• Avoid vaccinations with live virus vaccines (eg, measles, mumps, oral polio) while you are using Doxorubicin. Talk with your doctor before you receive any vaccine.


• Doxorubicin may cause the urine to turn red. This is harmless and usually goes away 1 to 2 days after receiving a dose of Doxorubicin.


• Doxorubicin may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Doxorubicin. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Lab tests, including liver and kidney function, complete blood cell counts, blood uric acid and electrolyte levels, and heart function, may be performed to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Tell your doctor or dentist that you take Doxorubicin before you receive any medical or dental care, emergency care, or surgery.


• Use Doxorubicin with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.


• Caution is advised when using Doxorubicin in CHILDREN; they may be more sensitive to its effects, especially heart problems (eg heart failure) and developing a certain other type of cancer (AML).


• Doxorubicin may damage sperm. Use effective birth control methods (eg, condoms) while using Doxorubicin. Discuss any questions or concerns with your doctor.


• Women using Doxorubicin may develop absence of menstrual periods or early menopause.


• PREGNANCY and BREAST-FEEDING: Doxorubicin has been shown to cause harm to the fetus. Avoid becoming pregnant while you are using it. If you are able to become pregnant, talk with your doctor about using an effective form of birth control. If you become pregnant, discuss with your doctor the benefits and risks of using Doxorubicin during pregnancy. Doxorubicin is excreted in breast milk. Do not breast-feed while using Doxorubicin.

Possible side effects of Doxorubicin:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; hair loss; loss of appetite; nausea; stomach pain; tiredness; weakness; weight changes.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; dizziness; flushed face; tightness in the chest; swelling of the mouth, face, lips, or tongue); absence of menstrual cycle; black, tarry stools; chest pain; fainting; fast, slow, or irregular heartbeat; headache; loose or bloody stools; pain, redness, burning, stinging, swelling, or open sores at the injection site; rectal bleeding or irritation; redness or discharge of the eyes; redness, pain, swelling, peeling, tingling, or blistering of the palms of the hands and the soles of the feet; severe or persistent nausea or vomiting; shortness of breath; sudden, unexplained weight gain; swelling of the hands, ankles, or feet; swelling or soreness of the mouth or tongue; symptoms of dehydration (eg, dry mouth or eyes, decreased urination, fast heartbeat, sluggishness, unusual thirst); symptoms of infection (eg, fever, chills, cough, sore throat, burning or painful urination); unusual bruising or bleeding; unusual tiredness or weakness; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include swelling or soreness of the mouth or tongue; unusual bruising or bleeding.

Proper storage of Doxorubicin:

Doxorubicin is usually handled and stored by a health care provider. If you are using Doxorubicin at home, store Doxorubicin as directed by your pharmacist or health care provider. Keep Doxorubicin out of the reach of children and away from pets.

General information:

• If you have any questions about Doxorubicin, please talk with your doctor, pharmacist, or other health care provider.


• Doxorubicin is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Doxorubicin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Doxorubicin resources

• Doxorubicin Use in Pregnancy & Breastfeeding
• Doxorubicin Drug Interactions
• Doxorubicin Support Group
• 2 Reviews for Doxorubicin - Add your own review/rating

• Doxorubicin Prescribing Information (FDA)


• Adriamycin Prescribing Information (FDA)


• Doxorubicin Hydrochloride Monograph (AHFS DI)


• Rubex Prescribing Information (FDA)


• doxorubicin Concise Consumer Information (Cerner Multum)


• doxorubicin Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information

Compare Doxorubicin with other medications

• Acute Lymphoblastic Leukemia
• Acute Myeloblastic Leukemia
• Bladder Cancer
• Breast Cancer
• Cancer
• Hodgkin's Lymphoma
• Lung Cancer
• Lymphoma
• Multiple Myeloma
• Neuroblastoma
• Osteosarcoma
• Ovarian Cancer
• Soft Tissue Sarcoma
• Stomach Cancer
• Thyroid Cancer
• Wilms' Tumor

Xerese

Xerese is a brand name of acyclovir/hydrocortisone topical, approved by the FDA in the following formulation(s):

XERESE (acyclovir; hydrocortisone - cream; topical)

• 
  Manufacturer: VALEANT INTL
  
  Approval date: July 31, 2009
  
  Strength(s): 5%;1% ^[RLD]

Has a generic version of Xerese been approved?

No. There is currently no therapeutically equivalent version of Xerese available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xerese. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Nucleoside analogs in combination therapy of herpes simplex infections
  Patent 6,514,980
  Issued: February 4, 2003
  Inventor(s): Malcolm Richard; Boyd
  Assignee(s): Novartis International Pharmaceutical Ltd.
  A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
  
  Patent expiration dates:
  
  
  • January 24, 2017
    
    ✓ 
    Patent use: NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
    ✓ 
    Drug product
  
  



• 
  Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
  Patent 7,223,387
  Issued: May 29, 2007
  Inventor(s): Lekare; Gunilla
  Assignee(s): Medivir AB
  A topical composition comprising an antiinflammatory glucocorticoid and a nucleoside analogue antiviral agent in a pharmaceutical carrier characterized in that the carrier comprises about 15 to about 25 weight % propylene glycol and about 10 to about 25 weight percent isopropyl C12–C22 alkanoic ester. The compositions have utility in the treatment or prophylaxis of herpesvirus infections and exhibit superior antiviral and therapeutic efficacy and an improved shelf life.
  
  Patent expiration dates:
  
  
  • February 28, 2021
    
    ✓ 
    Patent use: NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical combination
  Patent RE39264
  Issued: September 5, 2006
  Inventor(s): Harmenberg; Johan & Kristofferson; Ann Harriet Margareta
  Assignee(s): Medivir AB
  The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.
  
  Patent expiration dates:
  
  
  • February 2, 2016
    
    ✓ 
    Patent use: NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • July 31, 2012 - NEW COMBINATION
  
  

See also...

• Xerese Cream Consumer Information (Wolters Kluwer)
• Xerese Consumer Information (Cerner Multum)
• Xerese Advanced Consumer Information (Micromedex)
• Acyclovir/Hydrocortisone Cream Consumer Information (Wolters Kluwer)
• Acyclovir and hydrocortisone topical Consumer Information (Cerner Multum)
• Acyclovir and hydrocortisone Topical application Advanced Consumer Information (Micromedex)

Ap Inyect Solucion Cloruro Potasico

Ap Inyect Solucion Cloruro Potasico may be available in the countries listed below.

Ingredient matches for Ap Inyect Solucion Cloruro Potasico

Potassium Chloride

Potassium Chloride is reported as an ingredient of Ap Inyect Solucion Cloruro Potasico in the following countries:

• Spain

International Drug Name Search

Gastirol

Gastirol may be available in the countries listed below.

Ingredient matches for Gastirol

Tiquizium Bromide

Tiquizium Bromide is reported as an ingredient of Gastirol in the following countries:

• Japan

International Drug Name Search

Peptidin

Peptidin may be available in the countries listed below.

Ingredient matches for Peptidin

Omeprazole

Omeprazole is reported as an ingredient of Peptidin in the following countries:

• Colombia

International Drug Name Search

Prilagin

Prilagin may be available in the countries listed below.

Ingredient matches for Prilagin

Miconazole

Miconazole is reported as an ingredient of Prilagin in the following countries:

• Italy

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Prilagin in the following countries:

• Italy

International Drug Name Search

Rinderon-A

Rinderon-A may be available in the countries listed below.

Ingredient matches for Rinderon-A

Betamethasone

Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Rinderon-A in the following countries:

• Japan

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Rinderon-A in the following countries:

• Japan

International Drug Name Search

Sanfloks

Sanfloks may be available in the countries listed below.

Ingredient matches for Sanfloks

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Sanfloks in the following countries:

• Turkey

International Drug Name Search

Flupamid-SR

Flupamid-SR may be available in the countries listed below.

Ingredient matches for Flupamid-SR

Indapamide

Indapamide is reported as an ingredient of Flupamid-SR in the following countries:

• Turkey

International Drug Name Search

Nicardipine Aguettant

Nicardipine Aguettant may be available in the countries listed below.

Ingredient matches for Nicardipine Aguettant

Nicardipine

Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Nicardipine Aguettant in the following countries:

• France

International Drug Name Search

Licodin

Licodin may be available in the countries listed below.

Ingredient matches for Licodin

Ticlopidine

Ticlopidine is reported as an ingredient of Licodin in the following countries:

• Taiwan

International Drug Name Search

Lo-Lyndiol

Lo-Lyndiol may be available in the countries listed below.

Ingredient matches for Lo-Lyndiol

Lynestrenol

Lynestrenol is reported as an ingredient of Lo-Lyndiol in the following countries:

• Japan

Mestranol

Mestranol is reported as an ingredient of Lo-Lyndiol in the following countries:

• Japan

International Drug Name Search

Adsorbin

Adsorbin may be available in the countries listed below.

Ingredient matches for Adsorbin

Aluminium Silicate

Aluminium Silicate is reported as an ingredient of Adsorbin in the following countries:

• Japan

International Drug Name Search

Flubendazol

Flubendazol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Flubendazol

Flubendazole

Flubendazole is reported as an ingredient of Flubendazol in the following countries:

• Germany

International Drug Name Search

Effersol

Effersol may be available in the countries listed below.

Ingredient matches for Effersol

Calcium Citrate

Calcium Citrate is reported as an ingredient of Effersol in the following countries:

• South Africa

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Effersol in the following countries:

• South Africa

International Drug Name Search

Doxigen

Doxigen may be available in the countries listed below.

Ingredient matches for Doxigen

Doxycycline

Doxycycline is reported as an ingredient of Doxigen in the following countries:

• Bangladesh

International Drug Name Search

Mupirocin Calcium

Mupirocin Calcium may be available in the countries listed below.

Ingredient matches for Mupirocin Calcium

Mupirocin

Mupirocin Calcium (BANM, USAN) is known as Mupirocin in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Katrasic

Katrasic may be available in the countries listed below.

Ingredient matches for Katrasic

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Katrasic in the following countries:

• Indonesia

International Drug Name Search

Rombellin

Rombellin may be available in the countries listed below.

Ingredient matches for Rombellin

Biotin

Biotin is reported as an ingredient of Rombellin in the following countries:

• Switzerland

International Drug Name Search

Cefnil

Cefnil may be available in the countries listed below.

Ingredient matches for Cefnil

Cefdinir

Cefdinir is reported as an ingredient of Cefnil in the following countries:

• Japan

International Drug Name Search

Asmovent

Asmovent may be available in the countries listed below.

Ingredient matches for Asmovent

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Asmovent in the following countries:

• Vietnam

International Drug Name Search

Muttermin

Muttermin may be available in the countries listed below.

Ingredient matches for Muttermin

Sucralfate

Sucralfate is reported as an ingredient of Muttermin in the following countries:

• Japan

International Drug Name Search

Tokiozole

Tokiozole may be available in the countries listed below.

Ingredient matches for Tokiozole

Cefmetazole

Cefmetazole sodium salt (a derivative of Cefmetazole) is reported as an ingredient of Tokiozole in the following countries:

• Japan

International Drug Name Search

Konakion Roche

Konakion Roche may be available in the countries listed below.

Ingredient matches for Konakion Roche

Phytomenadione

Phytomenadione is reported as an ingredient of Konakion Roche in the following countries:

• Austria

International Drug Name Search

Roxithromycine Ratiopharm

Roxithromycine Ratiopharm may be available in the countries listed below.

Ingredient matches for Roxithromycine Ratiopharm

Roxithromycin

Roxithromycin is reported as an ingredient of Roxithromycine Ratiopharm in the following countries:

• France

International Drug Name Search

Lowastatyna

Lowastatyna may be available in the countries listed below.

Ingredient matches for Lowastatyna

Lovastatin

Lovastatin is reported as an ingredient of Lowastatyna in the following countries:

• Poland

International Drug Name Search

Clofazimine

In the US, Clofazimine (clofazimine systemic) is a member of the drug class leprostatics and is used to treat Leprosy, Leprosy - Dapsone-Resistant, Leprosy - Dapsone-Sensitive and Leprosy - Erythema Nodosum Leprosum.

US matches:

• Clofazimine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04BA01

CAS registry number (Chemical Abstracts Service)

0002030-63-9

Chemical Formula

C27-H22-Cl2-N4

Molecular Weight

473

Therapeutic Category

Antileprotic agent

Chemical Name

2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-

Foreign Names

• Clofaziminum (Latin)
• Clofazimin (German)
• Clofazimine (French)
• Clofazimina (Spanish)

Generic Names

• Clofazimine (OS: USAN, BANM)
• B 663 (IS)
• G 30320 (IS)
• NSC 141046 (IS)
• Riminophenazine (IS)
• Clofazimine (PH: Ph. Eur. 6, Ph. Franç. Xe édit, Ph. Int. 4, USP 32, BP 2010)
• Clofaziminum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Clofozine
  AstraZeneca, India



• Hansepran
  Sarabhai, India



• Lamcoin
  Pond's, Thailand



• Lampren
  Novartis, Netherlands; Padro, Spain; Sandoz, Japan



• Lamprene
  Novartis, Australia; Novartis, Ethiopia; Novartis, Ghana; Novartis, Guyana; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, New Zealand; Novartis, Sudan; Novartis, Tanzania; Novartis, United States; Novartis, Zimbabwe



• Lamprène
  Novartis, France

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Gonapeptyl

Gonapeptyl may be available in the countries listed below.

UK matches:

• Gonapeptyl Depot 3.75mg
• Gonapeptyl Depot 3.75 mg (SPC)

Ingredient matches for Gonapeptyl

Triptorelin

Triptorelin acetate (a derivative of Triptorelin) is reported as an ingredient of Gonapeptyl in the following countries:

• Argentina


• Bahrain


• Egypt


• France


• Greece


• Iran


• Iraq


• Ireland


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Oman


• Qatar


• Saudi Arabia


• Syria


• United Arab Emirates


• United Kingdom


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Silenor

In the US, Silenor (doxepin systemic) is a member of the following drug classes: miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants and is used to treat Insomnia.

US matches:

• Silenor

Ingredient matches for Silenor

Doxepin

Doxepin hydrochloride (a derivative of Doxepin) is reported as an ingredient of Silenor in the following countries:

• United States

International Drug Name Search

Neo Tomizol

Neo Tomizol may be available in the countries listed below.

Ingredient matches for Neo Tomizol

Carbimazole

Carbimazole is reported as an ingredient of Neo Tomizol in the following countries:

• Spain

International Drug Name Search

Laxbene

Laxbene may be available in the countries listed below.

Ingredient matches for Laxbene

Bisacodyl

Bisacodyl is reported as an ingredient of Laxbene in the following countries:

• Austria

International Drug Name Search

Gout, Acute Medications

Drugs associated with Gout, Acute

The following drugs and medications are in some way related to, or used in the treatment of Gout, Acute. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Gout, Acute

Medical Encyclopedia:

• Gout
• Gout - chronic

Drug List:

A-G-Profen

A-Methapred-Solution

Actiprofen

Actron

Addaprin

Advil

Advil-Liqui-Gels

Aflaxen

Aleve

All-Day-Pain-Relief

All-Day-Relief

Anaprox

Anaprox-Ds

Clinoril

Colcrys

Comfort-Pac-With-Naproxen

Depo-Medrol-Suspension

Ec-Naprosyn-Enteric-Coated-Tablets

Genpril

Haltran

Ibu

Ibu-200

Indocin

Indocin-Iv

Indocin-Sr-Sustained-Release-Capsules

Leader-Naproxen-Sodium

Medrol

Medrol-Dosepak

Methylprednisolone-Dose-Pack

Midol-Extended-Relief

Midol-Ib

Motrin

Motrin-Ib

Nalfon

Naprelan-Sustained-Release-Tablets

Naprosyn

Nuprin

Orudis

Orudis-Kt

Oruvail-Extended-Release-Capsules

Q-Profen

Solu-Medrol-Solution

Tolectin

Tolectin-600

Tolectin-Ds

Etec 1000

Etec 1000 may be available in the countries listed below.

Ingredient matches for Etec 1000

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Etec 1000 in the following countries:

• Chile

International Drug Name Search

Gemfibrozil Alternova

Gemfibrozil Alternova may be available in the countries listed below.

Ingredient matches for Gemfibrozil Alternova

Gemfibrozil

Gemfibrozil is reported as an ingredient of Gemfibrozil Alternova in the following countries:

• Denmark


• Netherlands

International Drug Name Search

Loxone

Loxone may be available in the countries listed below.

Ingredient matches for Loxone

Norfloxacin

Norfloxacin is reported as an ingredient of Loxone in the following countries:

• Myanmar


• Sri Lanka

International Drug Name Search

Fluprostenol Sodium

Fluprostenol Sodium may be available in the countries listed below.

Ingredient matches for Fluprostenol Sodium

Fluprostenol

Fluprostenol Sodium (BANM, USAN) is also known as Fluprostenol (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Longeril

Longeril may be available in the countries listed below.

Ingredient matches for Longeril

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Longeril in the following countries:

• Japan

International Drug Name Search

Loperid

Loperid may be available in the countries listed below.

Ingredient matches for Loperid

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperid in the following countries:

• Israel

International Drug Name Search

Pinamox

Pinamox may be available in the countries listed below.

Ingredient matches for Pinamox

Amoxicillin

Amoxicillin is reported as an ingredient of Pinamox in the following countries:

• Ireland

International Drug Name Search

Insulin Hypurin Porcine 30 / 70 Mix

Insulin Hypurin Porcine 30/70 Mix may be available in the countries listed below.

Ingredient matches for Insulin Hypurin Porcine 30/70 Mix

Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane porcine (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Insulin Hypurin Porcine 30/70 Mix in the following countries:

• Switzerland

International Drug Name Search

Kind-MD

Kind-MD may be available in the countries listed below.

Ingredient matches for Kind-MD

Nimesulide

Nimesulide is reported as an ingredient of Kind-MD in the following countries:

• India

International Drug Name Search

Sulpiril

Sulpiril may be available in the countries listed below.

Ingredient matches for Sulpiril

Sulpiride

Sulpiride is reported as an ingredient of Sulpiril in the following countries:

• Tunisia

International Drug Name Search

Propafenonã

Propafenonã may be available in the countries listed below.

Ingredient matches for Propafenonã

Propafenone

Propafenone is reported as an ingredient of Propafenonã in the following countries:

• Romania

International Drug Name Search

Rinalix

Rinalix may be available in the countries listed below.

Ingredient matches for Rinalix

Indapamide

Indapamide is reported as an ingredient of Rinalix in the following countries:

• Myanmar


• Singapore


• Sri Lanka

International Drug Name Search

Hyperphen

Hyperphen may be available in the countries listed below.

Ingredient matches for Hyperphen

Hydralazine

Hydralazine hydrochloride (a derivative of Hydralazine) is reported as an ingredient of Hyperphen in the following countries:

• South Africa

International Drug Name Search

Nystaderm comp.

Nystaderm comp. may be available in the countries listed below.

Ingredient matches for Nystaderm comp.

Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Nystaderm comp. in the following countries:

• Germany

Nystatin

Nystatin is reported as an ingredient of Nystaderm comp. in the following countries:

• Germany

International Drug Name Search

Haridol-D

Haridol-D may be available in the countries listed below.

Ingredient matches for Haridol-D

Haloperidol

Haloperidol decanoate (a derivative of Haloperidol) is reported as an ingredient of Haridol-D in the following countries:

• China

International Drug Name Search

Lopez

Lopez may be available in the countries listed below.

Ingredient matches for Lopez

Olanzapine

Olanzapine is reported as an ingredient of Lopez in the following countries:

• Bangladesh

International Drug Name Search

Erythromycin Estolate

Ingredient matches for Erythromycin Estolate

Erythromycin

Erythromycin Estolate (BAN, JAN, USAN) is known as Erythromycin in the US.

International Drug Name Search

Glossary

BAN	British Approved Name
JAN	Japanese Accepted Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.